G.Y.H. Lip | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where G.Y.H. Lip is active.

Explore More

Publication

Featured researches published by G.Y.H. Lip.

European Heart Journal | 2011

Guidelines for the management of atrial fibrillation (vol 31, pg 2369, 2010)

Paulus Kirchhof; G.Y.H. Lip; U Schotten; Irina Savelieva; I. C. Van Gelder; G. Hindricks; Bernard Prendergast; A. John Camm; Hein Heidbuchel; Sabine Ernst; N Al Attar; Andreas Goette; Bulent Gorenek; Magnus Heldal; Ottavio Alfieri; Stefan H. Hohloser; Annalisa Angelini; Philippe Kolh; Dan Atar; J.-Y. Le Heuzey; Paolo Colonna; P. Ponikowski; R. De Caterina; Frans H. Rutten; Johan De Sutter

European Heart Journal | 2018

P4816Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes in the daily practice

T.F. Chao; G.Y.H. Lip; Su-Jung Chen

European Heart Journal | 2018

P2297How could non-vitamin K antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation?

T.F. Chao; G.Y.H. Lip; Su-Jung Chen

European Heart Journal | 2018

P2913Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation

Tatjana S. Potpara; N Mujovic; Jelena Marinkovic; G.Y.H. Lip

European Heart Journal | 2018

P3845Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study

A. Nissen Bonde; G.Y.H. Lip; Anne-Lise Kamper; Gunnar H. Gislason; Christian Torp-Pedersen; Mark A. Hlatky; J. B. Olesen

European Heart Journal | 2018

P2905Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry

M.A. Esteve Pastor; I Roldan-Rabadan; José Miguel Rivera-Caravaca; V. Roldan; J Muniz; A. Cequier; V. Bertomeu-Martinez; L Badimon; P Rana-Miguez; M Ruiz-Ortiz; M Anguita; G.Y.H. Lip; Francisco Marín; Fantasiia

European Heart Journal | 2018

P2899Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification

A Bisson; A Bodin; A Bernard; Nicolas Clementy; M Gras; C Andre; Bertrand Pierre; Dominique Babuty; G.Y.H. Lip; Laurent Fauchier

European Heart Journal | 2018

P2298High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI

R. De Caterina; J.L. Lopez Sendon; Shamir R. Mehta; Grzegorz Opolski; Jonas Oldgren; Philippe-Gabriel Steg; Stefan H. Hohnloser; G.Y.H. Lip; Takeshi Kimura; Matias Nordaby; Eva Kleine; J. M. ten Berg; Deepak L. Bhatt; Christopher P. Cannon; Investigators

European Heart Journal | 2018

1360Incident comorbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): how frequent should we reassess stroke risk in these patients?

T.F. Chao; G.Y.H. Lip; Su-Jung Chen

European Heart Journal | 2018

1460Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

Megan Yee; Mathieu Kerneis; Tarek Nafee; R Travis; Gerald Chi; Roxana Mehran; P Wildegoose; Christoph Bode; Jonathan L. Halperin; Freek W.A. Verheugt; G.Y.H. Lip; Marc Cohen; Eric D. Peterson; K A A Fox; C.M. Gibson

Explore More